Informations générales (source: ClinicalTrials.gov)
SAfety and TOlerance of the Biopsies in Auto-immune Rare dIseases (SATORI)
Observational
University Hospital, Brest (Voir sur ClinicalTrials)
août 2021
février 2025
29 juin 2024
Biopsies are performed in several autoimmune diseases to diagnose or classify them
Tolerance and information of the patients have been poorly evlauated our objective is to
evaluate tolerance and information of the patients after the biopsies for salivary gland,
temporal arteries and neuromuscular.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CHU d'ANGERS - Angers - France | Geoffrey URBANSKI | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| CH de Quimper - 20007 - Quimper - France | Jérémy KERAËN | Contact (sur clinicalTrials) | |||
| CHRU de Brest - 29609 - Brest - France | Valerie Devauchelle-Pensec | Contact (sur clinicalTrials) | |||
| CHU de Bordeaux - 33000 - Bordeaux - France | Christophe RICHEZ RICHEZ | Contact (sur clinicalTrials) | |||
| CHU de LILLE - 59037 - Lille - France | Eric HACHULLA | Contact (sur clinicalTrials) | |||
| CHU de Marseille - Marseille - France | Emmanuelle CAMPANA-SALORT - | Contact (sur clinicalTrials) | |||
| CHU de Tours - Tours - France | Guillermo CARVAJAL ALEGRIA | Contact (sur clinicalTrials) | |||
| Hôpital de la Salpétrière - 75013 - Paris - France | Yves ALLENBACH | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- biospy required for the diagnsis or follow up aged of more than 18 non opposition
form
- biospy required for the diagnsis or follow up aged of more than 18 non opposition
form
- unable to consent demencia unable to fill the form and questionnaire patient Under
juridical protection refusing to participate